162 results
Page 4 of 9
424B5
dho1 oq3pt
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
eoqkju87b
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
823mw se4xmos4mlv
29 Apr 20
Other Events
8:06am
8-K
EX-99.1
4cnfbile39coiczt9fa
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-10.1
e4eallvxeg j4i7
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
s1ldyh1hb jwqxt6ppf
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
t8l6vv5agtxm3
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
eca1mogimtyq1dd 46
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
lq2kkuml0hd
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-99.1
l7c6sy0c
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am